Brainstorm Cell Therapeutics (BCLI) Short-term Investments (2012 - 2023)
Brainstorm Cell Therapeutics' Short-term Investments was $196,000 in Q3 2023, down 94.0% from $3.25 million a year earlier and down 3.0% from the prior quarter.
Brainstorm Cell Therapeutics (BCLI) Short-term Investments (2012 - 2023) Analysis & Trends
At the end of FY2022, Short-term Investments at Brainstorm Cell Therapeutics came in at $2.21 million, down 31.7% from FY2021.
- Short-term Investments shows a five-year compound annual growth rate of -16.0% (FY2017 to FY2022).
- In earlier years, Short-term Investments was $3.24 million in FY2021 (-21.2%), $4.11 million in FY2020, $33,000 in FY2019 (-99.5%) and $6.12 million in FY2018 (+16.1%).
- The Q3 2023 figure marks the lowest quarterly Short-term Investments since Q4 2019.
- Compared with a year earlier, Short-term Investments has declined for four straight quarters, with an average decline of 40.2% over the last eight quarters.
- The best year-over-year quarter for Short-term Investments over five years was Q2 2020 (growth of 156.5%); the worst was Q3 2019 (a decline of 99.7%).
- Per Business Quant data, BCLI's Short-term Investments in the three quarters before Q3 2023 was $202,000 (Q2 2023), $206,000 (Q1 2023) and $2.21 million (Q4 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Brainstorm Cell Therapeutics | 10.92 Mn | 10.85 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 196,000.00 |
| Jun 30, 2023 | 202,000.00 |
| Mar 31, 2023 | 206,000.00 |
| Dec 31, 2022 | 2.21 Mn |
| Sep 30, 2022 | 3.25 Mn |
| Jun 30, 2022 | 3.24 Mn |
| Mar 31, 2022 | 3.25 Mn |
| Dec 31, 2021 | 3.24 Mn |
| Sep 30, 2021 | 2.11 Mn |
| Jun 30, 2021 | 4.05 Mn |
| Mar 31, 2021 | 4.11 Mn |
| Dec 31, 2020 | 4.11 Mn |
| Sep 30, 2020 | 4.04 Mn |
| Jun 30, 2020 | 4.04 Mn |
| Mar 31, 2020 | 2.02 Mn |
| Dec 31, 2019 | 33,000.00 |
| Sep 30, 2019 | 34,000.00 |
| Jun 30, 2019 | 1.58 Mn |
| Mar 31, 2019 | 2.99 Mn |
| Dec 31, 2018 | 6.12 Mn |
Brainstorm Cell Therapeutics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=BCLI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "BCLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=BCLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();